类风湿关节炎单核细胞微小RNA与转录组分析:miR-146b在促炎进展中的作用
本研究对RA患者与健康对照的单核细胞进行miRNA-seq和RNA-seq联合分析,并检测SSc单核细胞miRNA。发现RA单核细胞191个显著变化的miRNA中20个预测可沉默炎症介质,选定miR-146b及其靶基因RARA;qPCR证实二者负相关,miR-146b与DAS28-CRP、DAS28-ESR相关,血清和滑液miR-146b升高。
要点
- RA单核细胞191个miRNA显著变化,20个预测负调控炎症介质。
- miR-146b与抗炎基因RARA表达负相关,过表达可降低THP-1细胞RARA。
- 循环miR-146b在RA血清和滑液中升高,或可预测疾病活动。
核心结论
- miR-146b预测负调控抗炎RARA转录本,循环miR-146b可作为预测RA促炎进展和疾病活动的生物标志物。
研究设计与样本
- 采用下一代测序对RA患者和健康对照单核细胞同时进行miRNA-seq和RNA-seq,并分析SSc单核细胞miRNA。
- 通过差异分析和负相关筛选miRNA-RNA对,并用qPCR验证。
主要发现
- RA单核细胞191个miRNA显著变化,其中20个候选miRNA预测可沉默炎症介质。
- miR-146b与RARA负相关评分最高(r=-0.97,P=1.75e-07,FDR=0.04)。
- qPCR证实miR-146b与RARA负相关(r=-0.45,P=0.04)。
- RA单核细胞miR-146b表达与DAS28-CRP和DAS28-ESR显著相关。
- 过表达miR-146b可降低THP-1细胞RARA表达,RA患者血清和滑液循环miR-146b显著升高。
关键数值与推荐
- miR-146b与RARA负相关r=-0.97,P=1.75e-07,FDR=0.04。
- qPCR验证miR-146b与RARA负相关r=-0.45,P=0.04。
临床怎么用
- 循环miR-146b水平可能作为预测RA疾病活动和促炎进展的候选生物标志物。
- miR-146b对RARA的负调控提示其参与RA单核细胞促炎进展的潜在机制。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To explore global miRNA and transcriptomic profiling of monocytes from RA patients compared with healthy controls in order to predict which aberrantly expressed miRNA can negatively modulate inflammatory molecules. METHODS: Using next-generation sequencing, we have performed simultaneous global analysis of miRNA (miRNA-seq) and transcriptome (RNA-seq) of monocytes from RA patients and healthy controls. Global analysis of miRNA of SSc monocytes was also performed. Following differential analysis and negative correlation, miRNA-RNA pairs were selected. RESULTS: We found that 20 specific miRNA candidates are predicted to silence inflammatory mediators, out of 191 significantly changed miRNAs in RA monocytes. Based on the highest scoring in terms of negative correlation (r = -0.97, P = 1.75e-07, false discovery rate = 0.04) and the number of seeds in miRNA responsible for negative regulation, we selected miRNA-146b and its target gene anti-inflammatory retinoic acid receptor alpha (RARA). Similarly to next-generation sequencing, qPCR analysis also confirmed negative correlation between miRNA-146b and RARA expression (r = -0.45, P = 0.04). Additionally, miRNA-146b expression in RA monocytes significantly correlated with clinical parameters including DAS28 for RA with CRP (DAS28-CRP) and ESR (DAS28-ESR), whereas overexpression of miRNA-146b was able to functionally reduce RARA expression in the human monocytic cell line THP-1. Finally, circulating miRNA-146b expression in sera and SFs was significantly elevated in RA patients. CONCLUSIONS: Overall, in this study we have identified a new miRNA-146b candidate that is predicted to negatively regulate the anti-inflammatory RARA transcript, whereas circulating miRNA-146b level can be used as a biomarker predicting pro-inflammatory RA progression and disease activity.
引用
- Ciechomska M, Wojtas B, Bonek K, et al. Comprehensive microRNA and transcriptomic profiling of rheumatoid arthritis monocytes: role of microRNA-146b in pro-inflammatory progression. Rheumatology (Oxford). 2021. PMID: 34009317. doi:10.1093/rheumatology/keab407
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。